Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of HSK16149 capsule in Chinese patients with herpetic neuralgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpetic Neuralgia

Drugs mentioned

• HSK16149

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Herpetic Neuralgia | Phase 2 | Status: COMPLETED